Hims & Hers Health (HIMS) EBITDA Margin (2020 - 2026)
Hims & Hers Health (HIMS) posted EBITDA Margin of 12.88% for Q1 2026, down 966.25% sequentially from 1.49% in Q4 2025, and down 2276.0% YoY from 0.59% in Q1 2025.
Hims & Hers Health (HIMS) EBITDA Margin (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported EBITDA Margin for 7 years, with the latest figure at 12.88% in Q1 2026.
- Quarterly EBITDA Margin fell 2276.0% year-over-year to 12.88% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.29% (down 745.0% YoY) and the FY2025 annual result came in at 4.5%, up 31.0% from the prior year.
- EBITDA Margin retreated to 12.88% in Q1 2026 per HIMS's latest filing, from 1.49% in the prior quarter.
- Over five years, EBITDA Margin peaked at 9.88% in Q1 2025 and troughed at 17.78% in Q2 2022.
- A 5-year average of 2.8% and a median of 0.16% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2026: EBITDA Margin soared 7584 bps in 2022, then slumped 2276 bps in 2026.
- Over 5 years, EBITDA Margin stood at 6.94% in 2022, then surged by 98 bps to 0.16% in 2023, then jumped by 2483 bps to 3.86% in 2024, then sank by 62 bps to 1.49% in 2025, then slumped by 966 bps to 12.88% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 12.88%, 1.49%, and 1.97% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -12.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.90% |
| Mar 31, 2026 | -12.88% |
| Dec 31, 2025 | 1.49% |
| Sep 30, 2025 | 1.97% |
| Jun 30, 2025 | 4.90% |
| Mar 31, 2025 | 9.88% |
| Dec 31, 2024 | 3.86% |
| Sep 30, 2024 | 5.57% |
| Jun 30, 2024 | 3.49% |
| Mar 31, 2024 | 3.56% |
| Dec 31, 2023 | -0.16% |
| Sep 30, 2023 | -3.77% |
| Jun 30, 2023 | -4.44% |
| Mar 31, 2023 | -5.90% |
| Dec 31, 2022 | -6.94% |
| Sep 30, 2022 | -13.80% |
| Jun 30, 2022 | -17.78% |
| Mar 31, 2022 | -16.70% |
| Dec 31, 2021 | -25.46% |
| Sep 30, 2021 | -37.29% |